Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Bromopyrimidine | HCID 78345 | — |
| Reactant | Sodium t-butoxide | HCID 23676156 | — |
| Reactant | HCID 58494526 | HCID 58494526 | — |
| Solvent | Dioxane Methanol | HCID 21966525 | — |
| Product | HCID 44565636 | HCID 44565636 | 25.8% |
Reaction Steps
A mixture of (4-{[4-(1H-benzimidazol-2-yl)piperidin-1-yl]carbonyl}phenyl)boronic acid (0.349 g, 1.00 mmol), 2-bromopyrimidine (0.175 g, 1.10 mmol) and sodium tert-butoxide (0.106 g, 1.10 mmol) are suspended in a mixture of MeOH/1,4-dioxane (1 mL/2 mL). The suspension is purged with N2 before adding 1,1′-bis(diphenylphosphino)ferrocene-palladium (II) dichloride dichloromethane complex (41 mg, 5 mol %). The reaction is heated to 90° C. for 18 h. The mixture is diluted with EtOAc, washed with saturated aqueous NaHCO3, dried over Na2SO4, filtered and concentrated under reduced pressure. The residue is triturated with MeCN and DCM to give 99 mg of [4-(1H-Benzimidazol-2-yl)piperidin-1-yl][4-(pyrimidin-2-yl)phenyl]methanone.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08609696B2 |
|---|
| Source dataset | uspto-grants-2013_12 |
|---|
| ORD ID | ord-23c624f73d774b088d5ecea32d3230e3 |
|---|
| Source note | uspto-grants-2013_12 |
|---|